The Financial Times released an article on 14 August 2020 highlighting the significant increase in healthcare IPOs of companies that are working towards a Covid-19 vaccine. According to Martin Steinbach, Head of EY’s IPO and listing services EMEIA, “2020’s initial...
In 2016 a synthetic alternative (rFC) to horseshoe crab blood, used in bacterial infection detection for injectable procedures, was licensed. And yet horseshoe crabs are both threatened with extinction and in line for preservation due to Covid-19 and its...
Researchers at Vanderbilt University Medical Centre (VUMC), based in Amsterdam, have recently published optimistic results from monoclonal antibody preclinical trials in Nature Medicine that could potentially be a breakthrough in the search for both a curative for the Covid-19...
A framework allowing a more sensible approach to health data collection In our previous blog we outlined the pressure on hospital margins and the entire hospital business model as a direct result of Covid-19. One solution is the sale by...